Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury

NCT03069820 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Liver Injury, Drug-Induced

Interventions

DRUG: docetaxel and cisplatin

Sponsor

Second Affiliated Hospital of Nanchang University